1.65
-0.05(-2.94%)
Currency In USD
| Previous Close | 1.7 |
| Open | 1.71 |
| Day High | 1.71 |
| Day Low | 1.64 |
| 52-Week High | 6.23 |
| 52-Week Low | 1.09 |
| Volume | 210,573 |
| Average Volume | 11.03M |
| Market Cap | 5.39M |
| PE | -0.54 |
| EPS | -3.06 |
| Moving Average 50 Days | 2.41 |
| Moving Average 200 Days | 2.16 |
| Change | -0.05 |
If you invested $1000 in Soligenix, Inc. (SNGX) 10 years ago, it would be worth $0.64 as of October 21, 2025 at a share price of $1.641. Whereas If you bought $1000 worth of Soligenix, Inc. (SNGX) shares 5 years ago, it would be worth $4.14 as of October 21, 2025 at a share price of $1.641.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Soligenix Inc. (NASDAQ: SNGX) Proprietary Platform Aims to Meet Growing Need for Effective CTCL Therapy
GlobeNewswire Inc.
Aug 07, 2025 12:30 PM GMT
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Soligenix Inc. (NASDAQ: SNGX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrand
Soligenix Inc. (NASDAQ: SNGX) Innovative Platform Provides Novel Treatment for Underserved CTCL Space
GlobeNewswire Inc.
Aug 05, 2025 12:30 PM GMT
NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Soligenix Inc. (NASDAQ: SNGX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrand
Soligenix, Inc. to Present at the 2024 ThinkEquity Conference
GlobeNewswire Inc.
Oct 24, 2024 11:30 AM GMT
PRINCETON, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Soligenix, Inc. (Nasdaq: SNGX) (“Soligenix” or the “Company”) a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unme